Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathways

Raymond E Menard1, Raymond R Mattingly

  • 1Department of Pharmacology, Wayne State University, 540 E. Canfield, Room 6326, Detroit, MI 48201, USA.

Cellular Signalling
|October 25, 2003
PubMed

Insights

p21-activated kinases (PAKs) are crucial serine-threonine protein kinases. This study reveals multiple pathways, including Ras-dependent ones, activate PAK1 using various agonists like LPA and EGF.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • p21-activated kinases (PAKs) are mammalian Ste20-like serine-threonine protein kinases.
  • PAK1 is implicated in various cellular processes, but its activation mechanisms are complex.

Purpose of the Study:

  • To elucidate the diverse signaling pathways that regulate PAK1 activation.
  • To investigate the roles of small GTPases (Ras, Rac, Cdc42, RhoA) and upstream kinases in PAK1 stimulation.

Main Methods:

  • Stimulation of PAK1 using agonists: carbachol, lysophosphatidic acid (LPA), epidermal growth factor (EGF), and phorbol 12-myristate 13-acetate (PMA).
  • Utilized dominant-negative and active forms of Ras, Rac, and Cdc42 to assess their roles in PAK1 activation.
  • Employed inhibitors for EGF receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI3-kinase), and protein kinase C (PKC).

Main Results:

  • PAK1 activation by all tested agonists was inhibited by dominant-negative Ras, Rac, and Cdc42.
  • Active Rac1 and Cdc42 independently induced maximal PAK1 activation.
  • EGF-induced PAK1 activation involved PI3-kinase, while muscarinic receptor stimulation was EGF-R-dependent.
  • LPA-mediated PAK1 activation was independent of PI3-kinase and EGF receptor but sensitive to RhoA inhibition.
  • Multiple Ras-dependent pathways contribute to PAK1 activation.

Conclusions:

  • PAK1 activation is orchestrated by multiple, converging, and diverging signaling pathways.
  • Small GTPases Rac and Cdc42 play critical roles in PAK1 activation.
  • Specific agonists utilize distinct upstream signaling cascades to modulate PAK1 activity.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...